Spanish Scientists Identify Cellular Cleanup Failure as Potential Therapeutic Target to Slow ALS Progression

Spanish scientists discover that a cellular cleanup system fails in ALS patients. Boosting this "selective cleaning" could slow motor neuron loss and disease.

By: AXL Media

Published: May 1, 2026, 6:50 AM EDT

Source: Information for this report was sourced from Universidad Miguel Hernandez de Elche

The Discovery of a Selective Protein Clearance Failure in Motor Neurons

A research team led by the Institute for Neurosciences in Spain has identified a critical breakdown in the cellular maintenance systems of patients suffering from Amyotrophic Lateral Sclerosis, or ALS. Published in Acta Neuropathologica Communications, the study highlights a significant reduction in chaperone-mediated autophagy, a highly selective process responsible for identifying and removing damaged proteins. Unlike general cellular recycling, this specific pathway is essential for maintaining neuronal homeostasis. When it fails, toxic proteins are allowed to accumulate, creating a lethal environment for the neurons responsible for muscle control and respiratory function.

Targeting the Toxic Accumulation of TDP-43 Protein Aggregates

In more than 90% of ALS cases, motor neurons are found to contain abnormal clumps of a protein called TDP-43, which has migrated from its functional home in the cell nucleus to form toxic aggregates in the cytoplasm. The researchers discovered that chaperone-mediated autophagy is the primary mechanism tasked with degrading TDP-43. When this system is compromised, the body loses its ability to prevent these protein clumps from forming. Professor Salvador Martínez, director of the laboratory at IN UMH-CSIC, noted that motor neurons are particularly vulnerable because they require exceptionally high levels of this specific "cleaning" activity to survive the metabolic stress of the disease.

Analyzing Human Spinal Cord Tissue to Reveal Activity Gaps

To reach these conclusions, the team utilized spinal cord tissue donated by ALS patients who had participated in clinical trials, comparing them against control samples from healthy donors. Using advanced immunohistochemistry and immunofluorescence techniques, the scientists measured the presence of LAMP2A, a protein that serves as a vital indicator of chaperone-mediated autophagy activity. The analysis revealed that while healthy motor neurons exhibited robust and specific LAMP2A activity, the neurons of ALS patients showed a marked decrease. This direct observation in human tissue provided a level of clarity that had previously been unattainable in animal models.